Heide Götze1, Sabine Taubenheim2, Andreas Dietz3, Florian Lordick4, Anja Mehnert5. 1. Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany. heide.goetze@medizin.uni-leipzig.de. 2. Local Clinical Cancer Registry Leipzig, University Medical Center Leipzig, Leipzig, Germany. 3. Department of Otolaryngology, Head and Neck Surgery, University Medical Center Leipzig, Leipzig, Germany. 4. University Cancer Center Leipzig (UCCL), University Medical Center Leipzig, Leipzig, Germany. 5. Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig, Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
Abstract
PURPOSE: Our study provides a detailed overview of comorbid conditions and health-related quality of life of long-term cancer survivors and analyses the impact of demographic, disease- and treatment-related characteristics. METHODS: We present data obtained from 1000 survivors across mixed tumour entities 5 and 10 years after cancer diagnosis in a cross-sectional study. We analyse the prevalence of physical symptoms and health conditions via self-report and health-related quality of life using the EORTC QLQ-C30 in comparison to gender- and age-matched reference values of the general population. RESULTS: Cancer survivors reported on average 5 comorbidities; 23% had 7 or more comorbid conditions. Cancer survivors reported higher physical symptom burden than the population-especially fatigue, insomnia and pain. Type and prevalence of long-term and late effects differ with disease-related factors (e.g. cancer type, treatment) and characteristics of the patient. Cancer survivors also reported lower quality of life than the population, especially in everyday activities, social life, psychological well-being and financial difficulties. There was a positive association between high quality of life and a low level of morbidity. CONCLUSIONS: The specific knowledge about physical long-term consequences for the individual types of cancer could raise awareness in health care professionals for high-risk patients and help to develop adequate prevention and survivorship-programs. IMPLICATIONS FOR CANCER SURVIVORS: Limitations in the mental health area underlines the importance of psycho-oncological survivorship-care-plans, which go beyond the time of rehabilitation. Special attention should be given to the financial situation of patients in long-term follow-up care.
PURPOSE: Our study provides a detailed overview of comorbid conditions and health-related quality of life of long-term cancer survivors and analyses the impact of demographic, disease- and treatment-related characteristics. METHODS: We present data obtained from 1000 survivors across mixed tumour entities 5 and 10 years after cancer diagnosis in a cross-sectional study. We analyse the prevalence of physical symptoms and health conditions via self-report and health-related quality of life using the EORTC QLQ-C30 in comparison to gender- and age-matched reference values of the general population. RESULTS:Cancer survivors reported on average 5 comorbidities; 23% had 7 or more comorbid conditions. Cancer survivors reported higher physical symptom burden than the population-especially fatigue, insomnia and pain. Type and prevalence of long-term and late effects differ with disease-related factors (e.g. cancer type, treatment) and characteristics of the patient. Cancer survivors also reported lower quality of life than the population, especially in everyday activities, social life, psychological well-being and financial difficulties. There was a positive association between high quality of life and a low level of morbidity. CONCLUSIONS: The specific knowledge about physical long-term consequences for the individual types of cancer could raise awareness in health care professionals for high-risk patients and help to develop adequate prevention and survivorship-programs. IMPLICATIONS FOR CANCER SURVIVORS: Limitations in the mental health area underlines the importance of psycho-oncological survivorship-care-plans, which go beyond the time of rehabilitation. Special attention should be given to the financial situation of patients in long-term follow-up care.
Entities:
Keywords:
Cancer survivorship; Comorbidities; Long-term effects; Quality of life
Authors: Julia H Rowland; Erin E Kent; Laura P Forsythe; Jon Håvard Loge; Lars Hjorth; Adam Glaser; Vittorio Mattioli; Sophie D Fosså Journal: Cancer Date: 2013-06-01 Impact factor: 6.860
Authors: Olga Husson; Harm R Haak; Laurien M Buffart; Willy-Anne Nieuwlaat; Wilma A Oranje; Floortje Mols; Johannes L Kuijpens; Jan Willem Coebergh; Lonneke V van de Poll-Franse Journal: Acta Oncol Date: 2012-11-26 Impact factor: 4.089
Authors: Jeannine M Brant; Susan Beck; William N Dudley; Patrick Cobb; Ginette Pepper; Christine Miaskowski Journal: Cancer Nurs Date: 2011 Jan-Feb Impact factor: 2.592
Authors: P A J Vissers; M S Y Thong; F Pouwer; M M J Zanders; J W W Coebergh; L V van de Poll-Franse Journal: J Cancer Surviv Date: 2013-08-06 Impact factor: 4.442
Authors: Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward Journal: Cancer Date: 2013-12-16 Impact factor: 6.860
Authors: Dejana Braithwaite; Dan H Moore; William A Satariano; Marilyn L Kwan; Robert A Hiatt; Candyce Kroenke; Bette J Caan Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-09 Impact factor: 4.254
Authors: Kate E Dibble; Richard N Baumgartner; Stephanie D Boone; Kathy B Baumgartner; Avonne E Connor Journal: Breast Cancer Res Treat Date: 2021-05-29 Impact factor: 4.624
Authors: Zev M Nakamura; Emily M Damone; Hannah P Herrick; Kirsten A Nyrop; Allison M Deal; A Tucker Brenizer; Hyman B Muss Journal: Support Care Cancer Date: 2022-01-19 Impact factor: 3.359
Authors: Jens Lehmann; Maria Rothmund; David Riedl; Gerhard Rumpold; Vincent Grote; Michael J Fischer; Bernhard Holzner Journal: Cancers (Basel) Date: 2021-12-24 Impact factor: 6.639
Authors: Mohammad A Karim; Amit G Singal; Robert L Ohsfeldt; Michael A Morrisey; Hye-Chung Kum Journal: Cancer Med Date: 2021-07-30 Impact factor: 4.452